Skip to main content
. 2022 May 17;11(5):982. doi: 10.3390/antiox11050982

Table 3.

Echocardiographic data for left ventricular systolic function.

C
(n = 14)
C + DAPA
(n = 14)
DM
(n = 20)
DM + DAPA
(n = 20)
EFS (%) 52.9 ± 4.51 49.5 ± 3.64 44.9 ± 4.73 * 46.5 ± 4.99
Ejection fraction 0.89 ± 0.03 0.87 ± 0.03 0.83 ± 0.04 * 0.84 ± 0.04 #
PWSV (mm/s) 39.9 ± 4.23 36.3 ± 4.58 * 30.1 ± 3.83 * 33.6 ± 4.85 §
Tei Index 0.48 ± 0.06 0.50 ± 0.06 0.55 ± 0.08 * 0.49 ± 0.07 §
Lateral TDI-S’ (cm/s) 3.50 (3.30–4.00) 3.65 (3.40–4.00) 3.30 (3.10–3.40) * 3.45 (3.10–3.70)
Septal TDI-S’ (cm/s) 3.63 ± 0.50 3.41 ± 0.36 3.22 ± 0.39 * 3.29 ± 0.35
Mean TDI-S’ (cm/s) 3.58 (3.45–3.80) 3.48 (3.35–3.70) 3.20 (3.10–3.40) * 3.35 (3.08–3.68)

Data are expressed as mean ± standard deviation or median and 25th and 75th percentiles. C: control; C + DAPA: control treated with dapagliflozin; DM: diabetes mellitus; DM + DAPA: DM treated with dapagliflozin; EFS: endocardial fractional shortening; PWSV: posterior wall shortening velocity; Tei: myocardial performance index; TDI-S’: tissue Doppler imaging for systolic velocity of the mitral annulus (lateral, septal, and average). ANOVA for a 2 × 2 factorial design and Tukey or Kruskal–Wallis and Dunn; * p < 0.05 vs. C; # p < 0.05 vs. C + DAPA; § p < 0.05 vs. DM.